Corteva (NYSE:CTVA – Free Report) had its price target upped by Jefferies Financial Group from $85.00 to $95.00 in a research note published on Monday,MarketScreener reports. They currently have a buy rating on the stock.
Several other equities analysts have also recently issued reports on CTVA. The Goldman Sachs Group reissued a “buy” rating and issued a $88.00 price objective on shares of Corteva in a research note on Thursday, February 5th. CICC Research lifted their target price on shares of Corteva from $70.00 to $80.00 and gave the company an “outperform” rating in a report on Wednesday, February 11th. BNP Paribas Exane increased their price target on shares of Corteva from $70.00 to $72.00 and gave the stock a “neutral” rating in a report on Monday, November 17th. Argus upgraded shares of Corteva to a “strong-buy” rating in a research report on Friday, January 16th. Finally, UBS Group cut Corteva from a “buy” rating to a “hold” rating in a research report on Monday, February 9th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and eight have issued a Hold rating to the stock. Based on data from MarketBeat.com, Corteva currently has a consensus rating of “Moderate Buy” and an average target price of $82.80.
Get Our Latest Report on Corteva
Corteva Stock Performance
Corteva (NYSE:CTVA – Get Free Report) last posted its quarterly earnings data on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.22. The company had revenue of $3.91 billion during the quarter, compared to analysts’ expectations of $4.23 billion. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The firm’s revenue for the quarter was down 1.7% on a year-over-year basis. During the same period last year, the firm earned $0.32 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, equities research analysts expect that Corteva will post 2.96 earnings per share for the current year.
Corteva Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Monday, March 16th. Stockholders of record on Monday, March 2nd will be given a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Monday, March 2nd. Corteva’s dividend payout ratio (DPR) is presently 45.57%.
Insider Buying and Selling at Corteva
In related news, insider Brian Titus sold 8,311 shares of the company’s stock in a transaction that occurred on Friday, February 20th. The stock was sold at an average price of $76.55, for a total value of $636,207.05. Following the sale, the insider owned 8,090 shares in the company, valued at $619,289.50. This represents a 50.67% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. 0.15% of the stock is currently owned by corporate insiders.
Institutional Trading of Corteva
A number of institutional investors have recently bought and sold shares of CTVA. Brighton Jones LLC raised its stake in shares of Corteva by 307.2% during the 4th quarter. Brighton Jones LLC now owns 15,588 shares of the company’s stock worth $888,000 after buying an additional 11,760 shares during the last quarter. Woodline Partners LP increased its holdings in Corteva by 40.3% during the 1st quarter. Woodline Partners LP now owns 57,919 shares of the company’s stock valued at $3,645,000 after acquiring an additional 16,644 shares in the last quarter. Y Intercept Hong Kong Ltd increased its holdings in Corteva by 40.5% during the 2nd quarter. Y Intercept Hong Kong Ltd now owns 18,463 shares of the company’s stock valued at $1,376,000 after acquiring an additional 5,326 shares in the last quarter. World Investment Advisors raised its position in Corteva by 21.8% during the second quarter. World Investment Advisors now owns 8,994 shares of the company’s stock worth $670,000 after acquiring an additional 1,608 shares during the last quarter. Finally, Arkadios Wealth Advisors lifted its holdings in shares of Corteva by 31.4% in the second quarter. Arkadios Wealth Advisors now owns 13,162 shares of the company’s stock valued at $981,000 after purchasing an additional 3,148 shares in the last quarter. 81.54% of the stock is currently owned by hedge funds and other institutional investors.
About Corteva
Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
Further Reading
- Five stocks we like better than Corteva
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- I’m 70 With $1.5M: Would Converting $120K a Year to a Roth Be Smart or a Costly Mistake? (Ask An Advisor)
- ALERT: Drop these 5 stocks before the market opens tomorrow!
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
